Dr. Abhijit A. Kulkarni, MD

Dr. Kulkarni practices at Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Dr. Kulkarni's NPI, 1609877521, was assigned on August 2, 2005. Dr. Kulkarni holds Pennsylvania license MD055089L.

Dr. Kulkarni's primary practice is Allegheny General Hospital, at 320 East North Avenue, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 359-3131.

Dr. Kulkarni's primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Dr. Kulkarni is also affiliated with West Penn Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Kulkarni to 4 more hospitals, 1 breast imaging center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kulkarni practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kulkarni's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Kulkarni's licenses on file in 2 states: Pennsylvania and West Virginia.

CMS data shows 298 Medicare services from Dr. Kulkarni across 11 procedure codes in 2024, for 203 Medicare patients. Medicare paid $30,934 for them.

CMS counts 203 Medicare patients who saw Dr. Kulkarni in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kulkarni's median patient age at 70, with 51% women.

In 2024, Dr. Kulkarni wrote 706 Medicare Part D claims for 321 patients. 86% of them were for generic drugs. CMS names the drug for 581 of them, across 11 drugs with 11 or more claims each, at $62,298 in total drug cost. In 2023, CMS named 561 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kulkarni for performance year 2024, reported through an alternative payment model (APM). Dr. Kulkarni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kulkarni as offering telehealth. CMS counts 133 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kulkarni, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Kulkarni, published from 2019 to 2025. The most frequent topics are Australia and Chromosome Aberrations.

CMS Open Payments shows 93 general payments to Dr. Kulkarni from 25 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 91% of the total. Abbvie Inc. paid the most, $22,721.